Together, our findings illuminate the role of HDAC1 in TDP‐43 proteinopathies and further support the hypothesis that restoring HDAC1 activity may be a feasible approach to treating FTLD‐TDP and ALS. Here, HDAC1 is linked to proteostasis deficiencies.